Robert Debbs
University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert Debbs.
Clinical Obstetrics and Gynecology | 2009
Robert Debbs; Janine Chen
Second trimester pregnancy loss and preterm delivery may be considered an obstetrical syndrome. A multifactorial approach to the diagnosis of true cervical insufficiency is paramount. Surgical modification of the cervix benefits those with at least 3 second trimester losses or preterm deliveries, those with 2 early second trimester losses when no other cause for loss is identified, and those with a previous second trimester loss or preterm birth with ultrasound findings of a short cervix defined as less than 25 mm. Multifetal pregnancies do not benefit from cerclage and causes harm in those with ultrasound or physical examination identified cervical changes.
Clinical Obstetrics and Gynecology | 1997
Juha Rasanen; Robert Debbs; James C. Huhta
Advances in fetal cardiac ultrasound have provided evidence of the natural history of the fetal cardiac response to many different stresses. Fetal echocardiography lends particular insight into the diverse etiologies of intrauterine growth restriction (IUGR). For example, structural malformation
Pediatric Research | 1997
Soraya Abbasi; Jorge Tolosa; Robert Debbs; M Grous; Jeffrey S. Gerdes
Our approach to the use of antenatal steroids is to treat all mothers in preterm labor, except those with insulin dependent diabetes mellitus, ≥ 34 weeks GA, or if delivery is imminent. Steroids are then repeated weekly until delivery. The objective of this study was to compare the impact of one full course (12 mg IM × 2 doses) of betamethasone with those who received an initial course plus serial doses of 12 mg IM weekly (2-12 doses) on incidence of RDS, BPD, PDA, Grade 3 & 4 IVH, sepsis, NEC, and ROP. 163 infants were born to mothers who received one course of steroids (BW = 2255 ± 871 gms, GA = 34.2 ± 4.4 weeks). 211 infants were exposed to serial antenatal steroid treatment (BW = 2087 ± 812 gms, GA = 33.6 ± 3.8 weeks). Chi square for linear trend was used to evaluate the dose response effect for all the infants, and for infants stratified by GA of 24 to 28 weeks(n = 48, BW 856 ± 235 gm SD & 894 ± 215 gm SD), 29 to 32 weeks (n = 77, BW 1688 ± 333 gm SD & 1558 ± 392 gm), and 32 to 36 wks (n = 138, BW 2221 ± 488 gm SD & 2222 ± 514 gm) for single and serial courses of steroids.
American Journal of Obstetrics and Gynecology | 2000
Soraya Abbasi; Daniel Hirsch; Jonathan M. Davis; Jorge Tolosa; Nicole O. Stouffer; Robert Debbs; Jeffrey S. Gerdes
American Journal of Obstetrics and Gynecology | 2007
Robert Debbs; Guillermo A. DeLa Vega; Stephanie Pearson; Harish M. Sehdev; Dominic Marchiano; Jack Ludmir
American Journal of Obstetrics and Gynecology | 2006
Robert Debbs; Stephanie Pearson; Guillermo De La Vega; Jack Ludmir
/data/revues/00029378/v176i1sP2/S0002937897806485/ | 2011
J. Rasanen; James C. Huhta; D. C. Wood; Robert Debbs; S.R. Weil; Stuart Weiner
/data/revues/00029378/v176i1sP2/S0002937897801998/ | 2011
Robert Debbs; Soraya Abbasi; Jorge Tolosa; Stuart Weiner; Ronald J. Wapner
American Journal of Obstetrics and Gynecology | 2006
Robert Debbs; Guillermo De La Vega; Harish M. Sehdev; Dominic Marchiano; Jack Ludmir
American Journal of Obstetrics and Gynecology | 1997
J. Rasanen; James C. Huhta; D. C. Wood; Robert Debbs; Stuart Weiner